Medicus Pharma Ltd. (MDCX) Financials
Annual revenue, profitability and per-share results for Medicus Pharma Ltd., as reported in SEC filings.
Revenue • FY2025
$0
Net income • FY2025
-$47.28M
▼ 323.8%YoY
Diluted EPS • FY2025
-$2.74
▼ 136.2%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $0 | -$47.28M | — | -$2.74 | — | — | — |
| FY2024 | $0 | -$11.16M | — | -$1.16 | — | — | — |
Figures as reported in Medicus Pharma Ltd.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a MDCX filing.
Get an email when MDCX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.